CENTER FOR DRUG EVALUATION AND

RESEARCH

 

 

 

APPLICATION NUMBER:

21-515

 

 

 

APPROVABLE LETTER 1

Back a Page
Next Page
Back to Wellbutrin XL NDA Index Page
Back to Main Index Page